Jiangsu Hengrui Medicine Co., Ltd.

This study tests a new medicine called SHR-3167 against a standard insulin (insulin degludec) in 173 adults with type 2 diabetes who already use basal insulin. The goal is to see which one controls blood sugar better and is safer. Participants will take their assigned treatment a…

This study tests whether adding two drugs (camrelizumab and rivoceranib) to a standard procedure called TACE can help people with incurable liver cancer live longer without their disease getting worse. About 423 adults with liver cancer that cannot be removed by surgery are takin…

This study tests a new drug called SHR-A1811, given alone or with another drug (pertuzumab), against the current standard treatment for HER2-positive breast cancer that has come back or spread. About 868 women aged 18 to 75 with advanced HER2-positive breast cancer will take part…

This study tests a new drug called HRS-4642 combined with other cancer medicines in people with advanced solid tumors that have a specific genetic change (KRAS G12D). The goal is to check safety, find the best dose, and see if the combination shrinks tumors. About 47 adults aged …